Linked Data API

Show Search Form

Search Results

348259
star this property registered interest false more like this
star this property date less than 2015-06-03more like thismore than 2015-06-03
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health remove filter
star this property answering dept sort name Health more like this
star this property hansard heading Batten Disease: Health Services more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, what assessment he has made of the adequacy of provisions to treat people who have Batten Disease. more like this
star this property tabling member constituency Leeds North West more like this
star this property tabling member printed
Greg Mulholland more like this
star this property uin 994 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2015-06-12more like thismore than 2015-06-12
star this property answer text <p>The neuronal ceriod lipofuscinoses (Batten disease) are a set of severely disabling degenerative diseases. Care is given in regional paediatric neuroscience centres and by local teams. We are advised by NHS England that it is at an early stage of discussion about the possibility of establishing expert centres for Batten disease. This disease does not feature in the highly specialised work programme for 2015/16 but NHS England will be considering it for inclusion in the 2016/17 work programme.</p><p> </p> more like this
star this property answering member constituency Battersea more like this
star this property answering member printed Jane Ellison remove filter
star this property question first answered
less than 2015-06-12T10:58:52.02Zmore like thismore than 2015-06-12T10:58:52.02Z
star this property answering member
3918
star this property label Biography information for Jane Ellison more like this
star this property tabling member
1540
unstar this property label Biography information for Greg Mulholland more like this
418223
star this property registered interest false more like this
star this property date less than 2015-09-10more like thismore than 2015-09-10
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health remove filter
star this property answering dept sort name Health more like this
star this property hansard heading Orthopaedics more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, what steps his Department is taking to reduce the number of lower limb amputations associated with diabetes and peripheral arterial disease. more like this
star this property tabling member constituency Ealing, Southall more like this
star this property tabling member printed
Mr Virendra Sharma more like this
star this property uin 9929 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2015-09-18more like thismore than 2015-09-18
star this property answer text <p>It is the responsibility of clinical commissioning groups (CCGs) to commission the majority of services for people with diabetes. The CCG Outcomes Indicator Set contains a number of indicators which are relevant to the delivery of of diabetes care, including an indicator relating to complications associated with diabetes including emergency admission for lower limb amputation.</p><p> </p><p> </p><p> </p><p>The latest National Diabetes Audit (NDA) shows that over 85% of all those with diabetes in England and Wales received a foot examination in 2012/13. A new module of the NDA, the National Diabetes Foot Care Audit, has been launched to establish the extent to which national guidelines on the management of diabetic foot disease are being met. The audit will provide local teams with the evidence needed to tackle identified differences in practice which will lead to an overall improvement in the management and outcomes for patients. Local and national level results will be available in March 2016.</p><p> </p><p> </p><p> </p><p>The latest NDA also demonstrates significant reductions in the risk of developing heart failure for individuals with both Type 1 and Type 2 diabetes, significant reductions in mortality for individuals with Type 2 diabetes, as well as trends showing a reduction in the risk for any individual with diabetes of developing angina, heart attack, stroke, major amputation and end-stage kidney disease.</p><p> </p><p> </p><p> </p><p>Tackling diabetes is of great concern to this Covernment. Building on the National Diabetes Prevention Programme, the Department is developing its plans to improve outcomes for those at risk of and with diabetes. These will be announced in due course.</p><p> </p><p><strong> </strong></p><p> </p>
star this property answering member constituency Battersea more like this
star this property answering member printed Jane Ellison remove filter
star this property question first answered
less than 2015-09-18T09:55:36.83Zmore like thismore than 2015-09-18T09:55:36.83Z
star this property answering member
3918
star this property label Biography information for Jane Ellison more like this
star this property tabling member
1604
unstar this property label Biography information for Mr Virendra Sharma more like this
418219
star this property registered interest false more like this
star this property date less than 2015-09-10more like thismore than 2015-09-10
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health remove filter
star this property answering dept sort name Health more like this
star this property hansard heading Gynaecology: Medical Treatments more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, what steps his Department is taking to improve patient access to uterine fibroid embolisation. more like this
star this property tabling member constituency Ealing, Southall more like this
star this property tabling member printed
Mr Virendra Sharma more like this
star this property uin 9891 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2015-09-18more like thismore than 2015-09-18
star this property answer text <p>Uterine fibroid embolisation is a treatment that is approved and recommended by the National Institute for Health and Care Excellence.</p><p> </p><p> </p><p> </p><p>A patient diagnosed with uterine fibroids requiring treatment will receive care and advice from their general practitioner (GP) in the first instance. If further treatment is required, the GP will refer the patient to a gynaecologist. It is the responsibility of specialist clinicians within clinical commissioning groups (CCGs) to recommend appropriate treatment to treat this condition, and for the CCGs to ensure they commission appropriate services to meet local demand.</p><p> </p> more like this
star this property answering member constituency Battersea more like this
star this property answering member printed Jane Ellison remove filter
star this property question first answered
less than 2015-09-18T10:01:35.357Zmore like thismore than 2015-09-18T10:01:35.357Z
star this property answering member
3918
star this property label Biography information for Jane Ellison more like this
star this property tabling member
1604
unstar this property label Biography information for Mr Virendra Sharma more like this
418259
star this property registered interest false more like this
star this property date less than 2015-09-10more like thismore than 2015-09-10
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health remove filter
star this property answering dept sort name Health more like this
star this property hansard heading Aspartame more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, what recent assessment his Department has made of the safety of aspartame in food and other consumable products. more like this
star this property tabling member constituency Bury North more like this
star this property tabling member printed
Mr David Nuttall more like this
star this property uin 9862 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2015-09-18more like thismore than 2015-09-18
star this property answer text <p>We are advised by the Food Standards Agency (FSA) that all food additives, including sweeteners, are only permitted after a robust evaluation of their safety. The foods in which the sweeteners can be used and their conditions of use are regulated under harmonised European Union legislation on food additives.</p><p> </p><p> </p><p> </p><p>The results of an FSA funded study on aspartame were published in March 2015. The study was designed to examine whether self-diagnosed individuals exhibit any reactions which can be observed in a clinical setting, after consuming bars that do or do not contain aspartame. Participants showed no difference in their response whether they contained aspartame or not.</p><p> </p><p> </p><p> </p><p>As part of its systematic re-evaluation of all food additives, the European Food Safety Authority (EFSA) re-evaluated the safety of aspartame and concluded in December 2013 that 'aspartame and its breakdown products are safe for human consumption at current levels of exposure'. In undertaking their re-evaluation EFSA had access to all available, relevant scientific studies and data on aspartame.</p><p> </p><p> </p><p> </p><p>Officials in the FSA have regular discussions with industry, and other interested parties, on a range of issues. Since EFSA reaffirmed the safety on the current use of aspartame, these have not routinely included discussions on aspartame or other sweeteners.</p><p> </p><p> </p><p> </p>
star this property answering member constituency Battersea more like this
star this property answering member printed Jane Ellison remove filter
star this property grouped question UIN
9849 more like this
9850 more like this
9861 more like this
star this property question first answered
less than 2015-09-18T09:47:50.897Zmore like thismore than 2015-09-18T09:47:50.897Z
star this property answering member
3918
star this property label Biography information for Jane Ellison more like this
star this property tabling member
4140
unstar this property label Biography information for Mr David Nuttall more like this
418258
star this property registered interest false more like this
star this property date less than 2015-09-10more like thismore than 2015-09-10
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health remove filter
star this property answering dept sort name Health more like this
star this property hansard heading Artificial Sweeteners more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, what recent discussions his Department has had with the food industry and relevant professional bodies on the safety of (a) aspartame and (b) other artificial sweeteners. more like this
star this property tabling member constituency Bury North more like this
star this property tabling member printed
Mr David Nuttall more like this
star this property uin 9861 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2015-09-18more like thismore than 2015-09-18
star this property answer text <p>We are advised by the Food Standards Agency (FSA) that all food additives, including sweeteners, are only permitted after a robust evaluation of their safety. The foods in which the sweeteners can be used and their conditions of use are regulated under harmonised European Union legislation on food additives.</p><p> </p><p> </p><p> </p><p>The results of an FSA funded study on aspartame were published in March 2015. The study was designed to examine whether self-diagnosed individuals exhibit any reactions which can be observed in a clinical setting, after consuming bars that do or do not contain aspartame. Participants showed no difference in their response whether they contained aspartame or not.</p><p> </p><p> </p><p> </p><p>As part of its systematic re-evaluation of all food additives, the European Food Safety Authority (EFSA) re-evaluated the safety of aspartame and concluded in December 2013 that 'aspartame and its breakdown products are safe for human consumption at current levels of exposure'. In undertaking their re-evaluation EFSA had access to all available, relevant scientific studies and data on aspartame.</p><p> </p><p> </p><p> </p><p>Officials in the FSA have regular discussions with industry, and other interested parties, on a range of issues. Since EFSA reaffirmed the safety on the current use of aspartame, these have not routinely included discussions on aspartame or other sweeteners.</p><p> </p><p> </p><p> </p>
star this property answering member constituency Battersea more like this
star this property answering member printed Jane Ellison remove filter
star this property grouped question UIN
9849 more like this
9850 more like this
9862 more like this
star this property question first answered
less than 2015-09-18T09:47:50.82Zmore like thismore than 2015-09-18T09:47:50.82Z
star this property answering member
3918
star this property label Biography information for Jane Ellison more like this
star this property tabling member
4140
unstar this property label Biography information for Mr David Nuttall more like this
418257
star this property registered interest false more like this
star this property date less than 2015-09-10more like thismore than 2015-09-10
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health remove filter
star this property answering dept sort name Health more like this
star this property hansard heading Artificial Sweeteners more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, what research and discussions his Department has had with the food industry and relevant professional bodies over the safety of aspartame and other artificial sweeteners. more like this
star this property tabling member constituency Bury North more like this
star this property tabling member printed
Mr David Nuttall more like this
star this property uin 9850 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2015-09-18more like thismore than 2015-09-18
star this property answer text <p>We are advised by the Food Standards Agency (FSA) that all food additives, including sweeteners, are only permitted after a robust evaluation of their safety. The foods in which the sweeteners can be used and their conditions of use are regulated under harmonised European Union legislation on food additives.</p><p> </p><p> </p><p> </p><p>The results of an FSA funded study on aspartame were published in March 2015. The study was designed to examine whether self-diagnosed individuals exhibit any reactions which can be observed in a clinical setting, after consuming bars that do or do not contain aspartame. Participants showed no difference in their response whether they contained aspartame or not.</p><p> </p><p> </p><p> </p><p>As part of its systematic re-evaluation of all food additives, the European Food Safety Authority (EFSA) re-evaluated the safety of aspartame and concluded in December 2013 that 'aspartame and its breakdown products are safe for human consumption at current levels of exposure'. In undertaking their re-evaluation EFSA had access to all available, relevant scientific studies and data on aspartame.</p><p> </p><p> </p><p> </p><p>Officials in the FSA have regular discussions with industry, and other interested parties, on a range of issues. Since EFSA reaffirmed the safety on the current use of aspartame, these have not routinely included discussions on aspartame or other sweeteners.</p><p> </p><p> </p><p> </p>
star this property answering member constituency Battersea more like this
star this property answering member printed Jane Ellison remove filter
star this property grouped question UIN
9849 more like this
9861 more like this
9862 more like this
star this property question first answered
less than 2015-09-18T09:47:50.757Zmore like thismore than 2015-09-18T09:47:50.757Z
star this property answering member
3918
star this property label Biography information for Jane Ellison more like this
star this property tabling member
4140
unstar this property label Biography information for Mr David Nuttall more like this
418256
star this property registered interest false more like this
star this property date less than 2015-09-10more like thismore than 2015-09-10
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health remove filter
star this property answering dept sort name Health more like this
star this property hansard heading Aspartame more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, what research his Department has undertaken or commissioned on possible links between aspartame and (a) aggressive behaviour, (b) depression, (c) anxiety and (d) Graves' Disease. more like this
star this property tabling member constituency Bury North more like this
star this property tabling member printed
Mr David Nuttall more like this
star this property uin 9849 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2015-09-18more like thismore than 2015-09-18
star this property answer text <p>We are advised by the Food Standards Agency (FSA) that all food additives, including sweeteners, are only permitted after a robust evaluation of their safety. The foods in which the sweeteners can be used and their conditions of use are regulated under harmonised European Union legislation on food additives.</p><p> </p><p> </p><p> </p><p>The results of an FSA funded study on aspartame were published in March 2015. The study was designed to examine whether self-diagnosed individuals exhibit any reactions which can be observed in a clinical setting, after consuming bars that do or do not contain aspartame. Participants showed no difference in their response whether they contained aspartame or not.</p><p> </p><p> </p><p> </p><p>As part of its systematic re-evaluation of all food additives, the European Food Safety Authority (EFSA) re-evaluated the safety of aspartame and concluded in December 2013 that 'aspartame and its breakdown products are safe for human consumption at current levels of exposure'. In undertaking their re-evaluation EFSA had access to all available, relevant scientific studies and data on aspartame.</p><p> </p><p> </p><p> </p><p>Officials in the FSA have regular discussions with industry, and other interested parties, on a range of issues. Since EFSA reaffirmed the safety on the current use of aspartame, these have not routinely included discussions on aspartame or other sweeteners.</p><p> </p><p> </p><p> </p>
star this property answering member constituency Battersea more like this
star this property answering member printed Jane Ellison remove filter
star this property grouped question UIN
9850 more like this
9861 more like this
9862 more like this
star this property question first answered
less than 2015-09-18T09:47:50.63Zmore like thismore than 2015-09-18T09:47:50.63Z
star this property answering member
3918
star this property label Biography information for Jane Ellison more like this
star this property tabling member
4140
unstar this property label Biography information for Mr David Nuttall more like this
418072
star this property registered interest false more like this
star this property date less than 2015-09-09more like thismore than 2015-09-09
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health remove filter
star this property answering dept sort name Health more like this
star this property hansard heading Hernias: Surgery more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, what the average waiting time is for a NHS hernia operation for patients in (a) Coventry, (b) the West Midlands and (c) England. more like this
star this property tabling member constituency Coventry North East more like this
star this property tabling member printed
Colleen Fletcher more like this
star this property uin 9781 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2015-09-17more like thismore than 2015-09-17
star this property answer text <p>The information is shown in the following table. These data are from hospital episode statistics (HES) and measure the waiting time between decision to admit and admission to hospital.</p><p> </p><p> </p><p> </p><p>They are not the same as the referral to treatment waiting times data that monitor delivery of the NHS Constitution right to start consultant-led treatment within a maximum of 18 weeks from referral for non-urgent conditions. These data do not include condition specific information such as hernia operations.</p><p> </p><p> </p><p> </p><p>Median waiting time in days between decision to admit and admission to hospital for patients admitted for a main procedure of hernia, 2013-14</p><p> </p><table><tbody><tr><td><p> </p></td><td><p>Median waiting time (days)</p></td></tr><tr><td><p>University Hospitals Coventry and Warwickshire NHS Trust</p></td><td><p>91</p></td></tr><tr><td><p>West Midlands</p></td><td><p>68</p></td></tr><tr><td><p>England</p></td><td><p>60</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p><em>Source: </em>HES, Health and Social Care Information Centre</p><p> </p><p> </p><p> </p><p><em>Notes: </em></p><p> </p><p> </p><p> </p><p>1. Main procedure is the first recorded procedure or intervention in each episode, usually the most resource intensive procedure or intervention performed during the episode. It is appropriate to use main procedure when looking at admission details, (e.g. time waited), but a more complete count of episodes with a particular procedure is obtained by looking at the main and the secondary procedures.</p><p> </p><p>2. The following OPCS codes were used to identify hernia operations:</p><p> </p><p> </p><p> </p><p>G23.- Repair of diaphragmatic hernia</p><p> </p><p>R01.2 Fetoscopic insertion of tracheal plug for congenital diaphragmatic hernia</p><p> </p><p>R04.6 Percutaneous insertion of fetal tracheal plug for congenital diaphragmatic hernia</p><p> </p><p>T16.4 Repair of congenital diaphragmatic hernia</p><p> </p><p>T19.- Simple excision of inguinal hernial sac</p><p> </p><p>T20.- Primary repair of inguinal hernia</p><p> </p><p>T21.- Repair of recurrent inguinal hernia</p><p> </p><p>T22.- Primary repair of femoral hernia</p><p> </p><p>T23.- Repair of recurrent femoral hernia</p><p> </p><p>T24.- Primary repair of umbilical hernia</p><p> </p><p>T25.- Primary repair of incisional hernia</p><p> </p><p>T26.- Repair of recurrent incisional hernia</p><p> </p><p>T27.- Repair of other hernia of abdominal wall</p><p> </p><p>T97.- Repair of recurrent umbilical hernia</p><p> </p><p>T98.- Repair of recurrent other hernia of abdominal wall</p><p> </p><p>3. West Midlands is defined as the West Midlands Government Office Region (GOR) of treatment. These data are derived from the hospital provider code and indicate the GOR area within which the treatment took place</p><p> </p><p><strong> </strong></p><p> </p>
star this property answering member constituency Battersea more like this
star this property answering member printed Jane Ellison remove filter
star this property question first answered
less than 2015-09-17T14:36:41.57Zmore like thismore than 2015-09-17T14:36:41.57Z
star this property answering member
3918
star this property label Biography information for Jane Ellison more like this
star this property tabling member
4378
unstar this property label Biography information for Colleen Fletcher more like this
418022
star this property registered interest false more like this
star this property date less than 2015-09-09more like thismore than 2015-09-09
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health remove filter
star this property answering dept sort name Health more like this
star this property hansard heading Pancreatic Cancer more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, pursuant to the Answer of 9 July 2015 to Question 5351, what mechanisms are in place to assess whether the dietary and other standards set out in the service specifications for pancreatic cancer are being met. more like this
star this property tabling member constituency Newbury more like this
star this property tabling member printed
Richard Benyon more like this
star this property uin 9714 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2015-09-17more like thismore than 2015-09-17
star this property answer text <p>The standards set for pancreatic cancer are reviewed in two ways:</p><p> </p><p> </p><p> </p><p>- By local commissioning teams to check compliance against the service review with each provider. This is a formal process and providers not meeting the key requirements are required to produce an action plan. This includes compliance with multi-disciplinary team membership.</p><p> </p><p>- Where Cancer Peer Review applies to a service, providers are assessed and measures that are not met are followed up with the Trust Board.</p><p> </p><p> </p><p> </p><p>Some of the areas referred to in the service specification are linked services under the responsibility of clinical commissioning groups and are included so the relationships between different parts of the pathway are clear.</p><p> </p><p><strong> </strong></p><p> </p><p><strong> </strong></p><p> </p><p><strong> </strong></p><p> </p><p><strong> </strong></p><p> </p> more like this
star this property answering member constituency Battersea more like this
star this property answering member printed Jane Ellison remove filter
star this property question first answered
less than 2015-09-17T14:45:26.29Zmore like thismore than 2015-09-17T14:45:26.29Z
star this property answering member
3918
star this property label Biography information for Jane Ellison more like this
star this property tabling member
1547
unstar this property label Biography information for Richard Benyon more like this
418000
star this property registered interest false more like this
star this property date less than 2015-09-09more like thismore than 2015-09-09
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health remove filter
star this property answering dept sort name Health more like this
star this property hansard heading Defibrillators more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, what steps his Department is taking to ensure access for NHS patients to subcutaneous implantable cardiac defibrillators. more like this
star this property tabling member constituency Denton and Reddish more like this
star this property tabling member printed
Andrew Gwynne more like this
star this property uin 9712 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2015-09-16more like thismore than 2015-09-16
star this property answer text <p>Data on the number of implantations of subcutaneous implantable cardiac defibrillators and implantable cardiac defibrillators which took place in 2013-14, the last year for which data is available, are set out in the attached table.</p><p> </p><p> </p><p> </p><p>In 2013, the National Institute for Health and Care Excellence (NICE) produced Interventional Procedures Guidance on this technology for the prevention of sudden cardiac death, recommending that it should only be used with special arrangements for clinical governance, consent and audit or research.</p><p> </p><p> </p><p> </p><p>NICE’s interventional procedures guidance assesses the efficacy and safety of interventional procedures, with the aim of protecting patients and helping clinicians, healthcare organisations and the National Health Service to introduce procedures appropriately. This guidance is not subject to the same statutory funding direction as NICE’s technology appraisal guidance.</p><p> </p><p> </p><p> </p><p>The Accelerated Access Review will make recommendations to the Government on reforms to accelerate access for NHS patients to innovative medicines and medical technologies (including devices, diagnostics and digital), making this country the best place in the world to design, develop and deploy these products. This includes looking at regulation, reimbursement, assessment and uptake.</p><p> </p>
star this property answering member constituency Battersea more like this
star this property answering member printed Jane Ellison remove filter
star this property grouped question UIN
9710 more like this
9711 more like this
star this property question first answered
less than 2015-09-16T15:43:11.613Zmore like thismore than 2015-09-16T15:43:11.613Z
star this property answering member
3918
star this property label Biography information for Jane Ellison more like this
star this property attachment
1
star this property file name FCEs implantable cardiac defibrillators (including subcutaneous) 2013-14.xlsx more like this
unstar this property title Implantations of cardiac defibrillators 2013-14 more like this
star this property tabling member
1506
unstar this property label Biography information for Andrew Gwynne more like this